Sign in

CIK 0001434316

  • Non-accelerated filer
  • Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
651311552
Phone
+1 858-875-1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,525
in 1 filing

Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adawi Kamal −$14K Chief Financial Officer sold 7% of stake

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-12 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2025-05-29 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2024-06-07 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2023-06-06 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-06-09 Jooss Karin Director Grant or award +8,650 9,848
2022-06-09 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +11,893 11,893
2022-06-03 Jooss Karin Director Sale −1,483 $22.82 $34K 1,198
2021-06-02 Jooss Karin Director Grant or award +2,681 2,681
2021-06-02 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +4,334 4,334
2020-05-01 Jooss Karin Director Grant or award · Stock Option (right to buy) +16,000 16,000
2019-05-03 Jooss Karin Director Grant or award · Stock Option (right to buy) +16,000 16,000
2019-03-14 Jooss Karin Director Grant or award · Stock Option (right to buy) +24,000 24,000

Page 1 of 1 · 12 trades